LEVOTIROXINA GSK
|
GlaxoSmithKline Biopharma
|
levotiroxina |
Terapéutica tiroidea |
100 mcg comp.x 50 | $24.250,52 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.063,08 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $12.611,35 AF $11.639,17 |
|
|
|
|
112 mcg comp.x 50 | $27.303,55 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.751,81 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $14.272,12 AF $13.031,43 |
|
|
|
|
125 mcg comp.x 50 | $30.458,91 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.922,13 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.878,35 AF $14.580,56 |
|
|
|
|
137 mcg comp.x 50 | $32.901,95 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.193,87 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.124,69 AF $15.777,26 |
|
|
|
|
150 mcg comp.x 50 | $34.224,14 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.293,49 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.760,34 AF $16.463,80 |
|
|
|
|
175 mcg comp.x 50 | $39.464,46 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.668,29 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $20.517,89 AF $18.946,57 |
|
|
|
|
25 mcg comp.x 50 | $7.707,52 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.398,55 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $1.884,21 |
|
|
|
|
50 mcg comp.x 50 | $11.611,42 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.427,34 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $5.788,11 |
|
|
|
|
75 mcg comp.x 50 | $16.276,39 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.796,04 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.538,77 AF $7.737,62 |
|
|
|
|
88 mcg comp.x 50 | $21.260,72 | (02/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.829,36 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.124,06 AF $10.136,66 |
|
|
|
|
|